Establishment of widely applicable DNA extraction methods to identify the origins of crude drugs derived from animals using molecular techniques
We established widely applicable DNA extraction methods to identify the origins of crude drugs derived from animals. Twenty-one samples including 17 kinds of crude drug derived from animals were examined. DNA was extracted from most of the crude drugs by adjustment of the QIAamp® DNA Mini Kit. DNA extraction was performed successfully using phenol to remove impurities after applying a proteinase treatment. DNA extraction was performed successfully by decalcification treatment using ethylenediaminetetraacetic acid (EDTA), before applying the proteinase treatment for crude drugs having high calcium content, such as those from oyster shell and cuttlefish bone. DNA could not be extracted from sea-ear shell using the EDTA decalcification treatment, but was extracted successfully using a TBONE EX KIT. The mitochondrial 16S ribosomal RNA (rRNA) gene region was amplified, and Basic Local Alignment Search Tool (BLAST) analysis was performed after sequencing. Polymerase chain reaction (PCR) products of approximately 600 bp in length were obtained from all samples except donkey glue, one of the two seahorses, and longgu. Drug origins were determined in all samples by sequence analysis based on the BLAST results, and match rates were >97 %. Moreover, 16 samples had a match rate >99 %. Our DNA extraction methods were widely applicable to evaluation of many crude drugs derived from animals, and proved very useful for identifying the origins of such drugs.
KeywordsCrude drugs Origin identification DNA extraction Mitochondrial 16S rRNA gene BLAST analysis
This study was supported by JSPS KAKENHI grant no. JP16K08304. The authors thank the Laboratory of Molecular and Biochemical Research, Research Support Center, Juntendo University Graduate School of Medicine for technical assistance. The authors are grateful to Mr. Daisuke Murayama (Tsumura & Co.) and Dr. Yutaka Yamamoto (Tochimoto Tenkaido Co., Ltd.) for providing some of the crude drugs of animal origin.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 11.Chen S, Yao H, Han J, Liu C, Song J, Shi L, Zhu Y, Ma X, Gao T, Pang X, Luo K, Li Y, Li X, Jia X, Lin Y, Leon C (2010) Validation of the ITS2 region as a novel DNA barcode for identifying medicinal plant species. PLoS ONE 5(1):e8613. https://doi.org/10.1371/journal.pone.0008613 CrossRefGoogle Scholar
- 14.Hashimoto A, Nishimura N, Kokusenya Y, Nakai H, Sato T (1998) Studies on “Signal” constituents for evaluation of animal crude drugs IV: application of DNA analytical technique to quality evaluation of medicines containing animal crude drugs. Nat Med 52:38–46Google Scholar
- 16.Lv P, Zhao Y, Qi F, Zhou X, You J, Qin Y, Zhang Y (2011) Authentication of equine DNA from highly processed donkey-hide glue (Colla Corii Asini) using SINE element. J Food Drug Anal 19:123–130Google Scholar
- 19.Palumbi S, Martin A, Romano S, McMillan WO, Stice L, Grabowski G (1991) The simple fools guide to PCR, version 2.0. University of Hawaii, Honolulu, p 28Google Scholar
- 20.Coghlan ML, Haile J, Houston J, Murray DC, White NE, Moolhuijzen P, Bellgard MI, Bunce M (2012) Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. PLoS Genet 8:e1002657. https://doi.org/10.1371/journal.pgen.1002657 CrossRefGoogle Scholar